Work Files Saved Searches
   My Account                                                  Search:   Quick/Number   Boolean   Advanced   Derwent    Help   


 The Delphion Integrated View

  Buy Now:   Buy PDF- 59pp  PDF  |   File History  |   Other choices   
  Tools:  Citation Link  |  Add to Work File:    
  View:  Expand Details   |  INPADOC   |  Jump to: 
  Go to:  Derwent  
 Email this to a friend  Email this to a friend 
       
Title: US5804201: Immunomodulatory peptides of vespid antigen 5
[ Derwent Title ]
>> View Certificate of Correction for this publication


Country: US United States of America

View Images High
Resolution

 Low
 Resolution

 
59 pages

 
Inventor: King, Te Piao; New York, NY

Assignee: The Rockefeller University, New York, NY
other patents from ROCKEFELLER UNIVERSITY (479685) (approx. 357)
 News, Profiles, Stocks and More about this company

Published / Filed: 1998-09-08 / 1996-03-11

Application Number: US1996000614935

IPC Code: Advanced: A61K 31/00; A61K 38/00; A61K 39/35; A61P 37/00; A61P 37/08; C07K 7/08; C07K 14/435;
Core: C07K 7/00; more...
IPC-7: A61K 38/04; A61K 39/35;

ECLA Code: C07K14/435A4B;

U.S. Class: Current: 424/275.1; 424/184.1; 424/185.1; 435/069.1; 530/300; 530/806; 530/858; 536/023.2; 536/023.5;
Original: 424/275.1; 424/184.1; 424/185.1; 435/069.1; 530/300; 530/806; 530/858; 536/023.2; 536/023.5;

Field of Search: 435/69.1 530/300,806-856 536/23.2,23.5 424/184.1,185.1,275.1

Government Interest:     The research leading to the present invention was supported by United States Public Health Service Grant No. AI-17021. The government may have certain rights in the invention.

Priority Number:
1996-03-11  US1996000614935

Abstract: The present invention is directed to immunogenic peptides from vespid antigen 5. These immunogenic peptides can be used in immunotherapy for vespid venom allergic individuals. The present invention is thus directed to T cell epitopes of vespid antigen 5 that can anergize T cell responses in sensitive individuals.

Attorney, Agent or Firm: Klauber & Jackson ;

Primary / Asst. Examiners: Knodf, Marian C.; Zeman, Mary K.

Maintenance Status: CC Certificate of Correction issued
View Certificate of Correction

INPADOC Legal Status: Show legal status actions          Buy Now: Family Legal Status Report

Designated Country: AL AM AP AZ BA BB BG BR BY CN CU CZ EE GE GH HU IL IS KG KP KR KZ LC  AT BE CH DE DK ES FI FR GB GR IE IT LI 

Family: Show 8 known family members

First Claim:
Show all 12 claims
What is claimed is:     1. A peptide characterized by the following properties:
  • a. having between 8 and 35 amino acid residues of vespid venom antigen 5; and
  • b. said peptide is antigenic for T cell proliferation in a mouse immunized with a vespid venom antigen 5, which mouse is a strain selected from the group consisting of BALB/c, ASW/Sn, C3H/He, and P/J.


Background / Summary: Show background / summary

Drawing Descriptions: Show drawing descriptions

Description: Show description

Forward References: Show 1 U.S. patent(s) that reference this one

       
U.S. References: Go to Result Set: All U.S. references   |  Forward references (1)   |   Backward references (0)   |   Citation Link

       
Foreign References: None

Other Abstract Info: CHEMABS 127(21)292054Z DERABS C1997-470817

Other References:
  • King et al. Jan. 1990 Protein Seq. Data Anal. 3: 263-266.
  • Hoffman et al. Jan. 1993 J Allergy Clin. Immunol. 92: 707-716. (10 pages) [ISI abstract]
  • Hoffman, "Hymenoptia Venom Proteins" in National Toxins, R.B. Singh (ed.), Plenum Publishing 6 (1996).
  • King et al., J. Allergy Clin. Immunol.98:588-600 (1996). (13 pages) Cited by 7 patents [ISI abstract]
  • Muller et al., J. Allergy Clin. Immunol. 97:426 (1996).
  • Forster et al. (1995) J. Allergy Clin. Immunol. 95:1229-35. (7 pages) Cited by 4 patents [ISI abstract]
  • King et al., J. Immunol., 154:577 (1995). (8 pages) Cited by 6 patents [ISI abstract]
  • Muller et al., J. Allergy Clin. Immunol. 96:395-402 (1995). (8 pages) Cited by 2 patents [ISI abstract]
  • Norman et al., J. Allergy Clin. Immunol. 95:259 (1995). (1 pages) Cited by 2 patents [ISI abstract]
  • Briner et al., Proc. Natl. Acad. Sci. U.S.A., 90:7608-12 (1993). (5 pages) Cited by 16 patents [ISI abstract]
  • Hoyne et al., J. Exp. Med., 178:1783-1788 (1993). (6 pages) Cited by 6 patents [ISI abstract]
  • T.P. King, in "Bronchial Asthma," edited by E.B. Weiss and M. Stein, Little Brown, Boston, pp. 43-49 (1993).
  • King et al., J. Allergy Clin. Immunol., 91:283 (1993). (1 pages) Cited by 4 patents [ISI abstract]
  • Lu et al., J. Immunol. 150:2823 (1993). (8 pages) Cited by 10 patents [ISI abstract]
  • P.S. Norman, Current Op. Immunol., 5:968 (1993). (6 pages) Cited by 3 patents [ISI abstract]
  • O'Hehir et al., Eruop. J. Clin. Invest., 23:763 (1993). (10 pages) Cited by 2 patents [ISI abstract]
  • Mizuku et al., Mammalian Genome, 3:274-280 (1992).
  • Ales-Martinez, et al., Immunol. Today, 12:201 (1991). (5 pages) Cited by 6 patents [ISI abstract]
  • O'Hehir et al., Ann. Rev. Immunol., 9:67 (1991). (29 pages) Cited by 11 patents [ISI abstract]
  • Fang et al., Proc. Natl. Acad. Sci., USA, 85:895-899 (1988). (5 pages) Cited by 13 patents
  • King, J. Allergy Clin. Immunol., 79:113 (1987). (8 pages) Cited by 6 patents
  • Hoffman, J. Allergy and Clin. Immunol., 75:611 (1985). (3 pages) Cited by 6 patents
  • King, et al., J. Allergy and Clin. Immunol., 75:621 (1985). (8 pages) Cited by 8 patents


  • Inquire Regarding Licensing

    Powered by Verity


    Plaques from Patent Awards      Gallery of Obscure PatentsNominate this for the Gallery...

    Thomson Reuters Copyright © 1997-2010 Thomson Reuters 
    Subscriptions  |  Web Seminars  |  Privacy  |  Terms & Conditions  |  Site Map  |  Contact Us  |  Help